Unlock instant, AI-driven research and patent intelligence for your innovation.

Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

An anti-inflammatory and active technology, applied in chemical instruments and methods, specific peptides, anti-inflammatory agents, etc., can solve problems such as undetermined meaning

Active Publication Date: 2014-01-08
THE ROCKEFELLER UNIV
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Parekh et al., Nature 316, 452 (1985), Rademacher et al., Proc. Natl. Acad. Sci. USA91, 6123 (1994), Matsumoto et al., 128, 621 (2000), Holland et al. .Biophys.Acta Dec27; [Epub ahead of print] 2005. Changes in IgG glycoforms have been reported to correlate with age and immunity, although the significance of these changes in vivo has not been established

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
  • Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
  • Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] Example 1. IVIG with increased sialic acid content exhibits reduced cytotoxicity

[0075] To test whether IgG-specific glycoforms are involved in modulating antibody effector functions, the role of specific Asn297-linked glycoforms in mediating the cytotoxicity of specific IgG monoclonal antibodies was investigated. Specific carbohydrate composition and structure of antiplatelet antibody derived from 6A6 hybridoma detected by mass spectrometry ( figure 1 ), expressed by 293 cells as IgG12a or 2b switch variants, as previously described by Nitnmerjahn et al. in Immunity 23, 41 (2005). These antibodies contain the fewest sialic acid residues. Enrichment of sialic acid-containing species by Western elderberry agglutinin affinity chromatography to harvest antibodies enriched 60-80 times in sialic acid content figure 2 B and image 3 ). A comparison of the ability of sialylated and non-sialylated 6A6-IgG1 and 2b antibodies to mediate platelet clearance revealed that sia...

Embodiment 2

[0081] Example 2. Desialylation of IVIG reduces its anti-inflammatory effect in a mouse arthritis model

[0082] mouse

[0083] C57BL / 6 and NOD mice were purchased from Jackson Laboratories (Bar Harbor, ME). FcγRIIB - / - Mice were generated in the inventor's laboratory and backcrossed to the C57BL / 6 background for 12 generations. KRN TCR transgenic mice (K / B) of C57BL / 6 background were a kind gift of D. Mathis and C. Benoist (Harvard Medical School, Boston, MA) and bred with NOD mice to generate K / BxN mice. Female mice aged 8-10 weeks were used in all experiments and maintained at the Rockefeller University Animal Facility. All trials were conducted in accordance with federal law and institutional guidelines and were approved by The Rockefeller University (New York, NY).

[0084] Antibodies and soluble Fc receptors

[0085] A switch variant of the 6A6 antibody was prepared from transiently transfected 293T cells and subsequently purified with protein G according to Nimmerj...

Embodiment 3

[0087] Example 3. IVIG Fractions with Enriched Sialic Acid Content Reduce Inflammation in a Mouse Arthritis Model

[0088] Preparation of IVIG with increased sialic acid content

[0089] Since sialic acid is required to demonstrate the anti-inflammatory activity of IVIG, the basis for this high dose (1 g / kg) requirement for anti-inflammatory activity may be the limited concentration of sialylated IgG in the total IVIG preparation. IVIG was fractionated on a SNA-lectin affinity column to obtain IgG molecules enriched in sialic acid-modified glycan structures.

[0090] The protective effect of the sialic acid-rich fraction versus unfractionated IVIG was tested in a KxN serum-infused arthritis model. A 10-fold enhancement in the protective effect of the SNA-binding moiety was observed, so that 0.1 g / kg of SNA-enriched IVIG compared with 1 g / kg of unfractionated IVIG yielded equivalent protective results ( Figure 4 B, C). The distribution of serum half-life of IgG subtypes enr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a polypeptide containing at least one IgG Fc region region and a preparation method of the polypeptide. Compared with unpurified antibodies, the polypeptide has higher anti-inflammatory activity and lower cytotoxic activity.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Patent Application No. 60 / 789,383, filed April 5,2006. [0003] Statements related to federally funded research [0004] Research leading up to the present invention was funded in part by National Institutes of Health grant number AI034662. Accordingly, the United States Government may have certain rights in this invention. field of invention [0005] The present invention relates to novel methods for the design of therapeutic polypeptides for the treatment of inflammatory diseases. Background of the invention [0006] Although the cellular receptors for immunoglobulins were first identified nearly 40 years ago, their central role in the immune response has only been discovered in the past decade. They are critical in both the afferent and efferent phase of the immune response: setting thresholds for B cell activation and antibody production, regulating dendritic ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/00C12P21/08A61K39/395
CPCC07K16/18C07K16/06C07K2317/71C07K2317/41A61P29/00A61P37/00C07K16/00C12P21/005G01N33/6854A61K2039/505C07K2317/52C07K2317/76A61K47/68
Inventor 杰夫瑞·V·华弗治善藤金子尼莫雅恩·福克
Owner THE ROCKEFELLER UNIV